SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000921895-12-001793
Filing Date
2012-08-31
Accepted
2012-08-31 11:53:08
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO THE SCHEDULE 13G sc13ga107422che_08282012.htm SC 13G/A 195510
  Complete submission text file 0000921895-12-001793.txt   197030
Mailing Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611
Business Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611 3125066500
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6282 Investment Advice

Mailing Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043
Business Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043 650-210-2900
ChemoCentryx, Inc. (Subject) CIK: 0001340652 (see all company filings)

IRS No.: 943254365 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-86723 | Film No.: 121067654
SIC: 2834 Pharmaceutical Preparations